Ahead of the Curve: What the Future of Livestock Health Regulation Looks Like, and Who's Ready

02 Mar 2027
Livestock Care Delivery

In Focus: Cattle · Swine · Poultry · Antimicrobial resistance · Parasite resistance · Antibiotic alternatives · Parasiticides · Methane-reducing technology · Feed additives · EU Veterinary Medicines Regulation · Emissions targets

Antimicrobial resistance, parasiticide resistance and growing environmental expectations are changing which livestock medicines and technologies make it to market. This session puts the regulator's perspective centre stage, looking at where livestock medicines regulation is heading, where the biggest therapeutic gaps lie, and how innovators can work with regulators earlier to bring tomorrow's products to market faster.

Discussion points

  • The regulator's view on what's coming next
  • Closing therapeutic gaps in livestock medicines
  • Sustainability of existing medicines: resistance and environmental impact
  • Early regulator engagement for innovators
  • Regulatory pathways for novel products and technologies
  • Positioning portfolios for tomorrow's requirements
Speaker(s)
Carel du Marchie Sarvaas
Carel du Marchie Sarvaas, Executive Director - HealthforAnimals
Francisco Norris
Francisco Norris, Chief Executive Officer - ZELP
Abi Seager
Abi Seager, Chief Executive Officer - Veterinary Medicines Directorate (VMD)